Piper Sandler raised the firm’s price target on Bath & Body Works to $36 from $35 and keeps a Neutral rating on the shares. The firm notes the company delivered better than expected results both from the top line and continued cost savings to support margins. Guidance was also raised, but expectations remain below where they were prior to the Q2 guidance reduction, Piper adds.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BBWI:
- Bath & Body Works price target raised to $49 from $48 at Morgan Stanley
- Bath & Body Works price target raised to $38 from $32 at Wells Fargo
- Bath & Body Works price target raised to $52 from $51 at Deutsche Bank
- Bath & Body Works price target raised to $34 from $28 at Barclays
- Bath & Body Works Exceeds Q3 Expectations, Raises Guidance
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
